Literature DB >> 17040901

Hemoglobin-degrading plasmepsin II is active as a monomer.

Jun Liu1, Eva S Istvan, Daniel E Goldberg.   

Abstract

A family of aspartic proteases called plasmepsins is important for hemoglobin degradation in intraerythrocytic Plasmodium parasites. Plasmepsin II (PM II) is the best studied member of this family. PM II and its close orthologs and paralogs form homodimers with extensive interfaces in all known crystal structures. This raised the question whether the homodimer is the functional subunit of plasmepsins in solution. We have used gel filtration chromatography, site-directed mutagenesis, and analytical ultracentrifugation to study the oligomeric status of PM II in solution. Our results reveal that PM II exists mainly as a monomer in solution and that the monomer is fully functional for catalysis. A hydrophobic loop at the PM II monomer surface, which would be buried in a PM II dimer, is shown to be essential for the hemoglobin degradation capability of PM II.

Mesh:

Substances:

Year:  2006        PMID: 17040901     DOI: 10.1074/jbc.M608535200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  4 in total

Review 1.  Malaria parasite plasmepsins: More than just plain old degradative pepsins.

Authors:  Armiyaw S Nasamu; Alexander J Polino; Eva S Istvan; Daniel E Goldberg
Journal:  J Biol Chem       Date:  2020-05-04       Impact factor: 5.157

2.  Structural insights into the activation and inhibition of histo-aspartic protease from Plasmodium falciparum.

Authors:  Prasenjit Bhaumik; Huogen Xiao; Koushi Hidaka; Alla Gustchina; Yoshiaki Kiso; Rickey Y Yada; Alexander Wlodawer
Journal:  Biochemistry       Date:  2011-09-26       Impact factor: 3.162

Review 3.  Structural studies of vacuolar plasmepsins.

Authors:  Prasenjit Bhaumik; Alla Gustchina; Alexander Wlodawer
Journal:  Biochim Biophys Acta       Date:  2011-04-20

4.  Computational perspectives into plasmepsins structure-function relationship: implications to inhibitors design.

Authors:  Alejandro Gil L; Pedro A Valiente; Pedro G Pascutti; Tirso Pons
Journal:  J Trop Med       Date:  2011-07-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.